Veterinary Clinics of North America: Small Animal Practice 2010-07-01

Current use of pimobendan in canine patients with heart disease.

Adrian Boswood

文献索引：Vet. Clin. North Am. Small Anim. Pract. 40(4) , 571-80, (2010)

全文：HTML全文

摘要

Pimobendan is a drug with both inotropic and vasodilatory properties and is widely used for the treatment of heart failure in dogs. The best evidence regarding its efficacy is derived from several clinical studies of dogs with the two most common conditions that result in heart failure: dilated cardiomyopathy (DCM) and degenerative mitral valve disease (DMVD). The main studies addressing the effectiveness of pimobendan in dogs with DCM and DVMD are discussed in this article.